Attending ERS in London

Innovo Medical are attending the European Respiratory Society International Congress in London until September 7th. The ERS is in London for the first time to host the world’s largest and most influential meeting for respiratory physician’s, scientists and allied health care professionals. The congress is being held at ExCel London and located on the banks of the River Thames in East London, the site of the 2012 Olympic Games. If you would like to meet us there please get in touch by either using our Contact Form on this web site or calling Lynne on +44 (0)7917567641

Attending ESC in London

Lynne Ford of Innovo Medical will be attending the upcoming European Society of Cardiology (ESC) in London from Saturday 29th August – Wednesday 2nd September 2015. The congress is described as ‘the world’s largest & most influential cardiovascular event contributing to global awareness of the latest clinical trials & breakthrough discoveries’. For more information follow this link

If you would like to meet us there please get in touch by either using our Contact Form on this web site or calling Lynne on +44 (0) 7917567641

Happy Birthday Innovo!

Innovo Medical was 5 years old on July 23rd 2015 and to celebrate Innovo has had a complete revamp of its website and we now have a beautiful new logo. We hope you like our new logo and find the websites increased functionality enhances your on-line experience. This is by no means the end of the programme to update the website so look out for case studies and news items in the future. We would love to hear your comments regarding the update plus any suggestions of what you would find useful to have access to here, so please let us know by using our Contact Form.

Enrollment of Clinical Trial

DC Devices now Corvia Medical Inc. completes enrollment in the clinical trial of the first transcatheter device to treat diastolic heart failure. Innovo Medical was happy to provide both clinical & field support during initialisation of this CE mark study. Congratulations to all those who contributed to this exciting trial.